First-trimester determination of complications of late pregnancy

JAMA

Volumn 303, Issue 6, 2010, Pages 561-562

  Smith, Gordon C S ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACENTA PROTEIN;

ANEUPLOIDY; CONCEPTION; DOWN SYNDROME; EDITORIAL; EMBRYO DEVELOPMENT; FERTILIZATION; FETUS DEVELOPMENT; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HEMATOCRIT; HUMAN; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; MENSTRUAL CYCLE; MENSTRUATION; PLACENTA FUNCTION; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURITY; PRENATAL CARE; PRIORITY JOURNAL; RISK ASSESSMENT; STILLBIRTH; THIRD TRIMESTER PREGNANCY;

EID: 76749121839     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.102     Document Type: Editorial

References (14)

1. Bynum W. Discarded diagnoses. Lancet. 2002;359(9309):898.
2. Mook-Kanamori DO, Steegers EAP, Eilers PH, Raat H, Hofman A, Jaddoe VWV. Risk factors and outcomes associated with first-trimester fetal growth restriction. JAMA. 2010;303(6):527-534.
3. Smith GCS, Smith MFS, McNay MB, Fleming JEE. First-trimester growth and the risk of low birth weight. N Engl J Med. 1998;339(25):1817-1822.
4. Bukowski R, Smith GC, Malone FD, et al; FASTER Research Consortium. Fetal growth in early pregnancy and risk of delivering low birth weight infant: prospective cohort study. BMJ. 2007;334(7598):836.
5. Murphy JF, O'Riordan J, Newcombe RG, Coles EC, Pearson JF. Relation of haemoglobin levels in first and second trimesters to outcome of pregnancy. Lancet. 1986;1(8488):992-995.
6. van den Elzen HJ, Cohen-Overbeek TE, Grobbee DE, Quartero RW, Wladimiroff JW. Early uterine artery Doppler velocimetry and the outcome of pregnancy in women aged 35 years and older. Ultrasound Obstet Gynecol. 1995;5(5):328-333.
7. Conover CA, Bale LK, Overgaard MT, et al. Metalloproteinase pregnancyassociated plasma protein A is a critical growth regulatory factor during fetal development. Development. 2004;131(5):1187-1194.
8. Smith GCS, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. Early pregnancy levels of pregnancy-associated plasma protein A and the risk of intra-uterine growth restriction, premature birth, pre-eclampsia and stillbirth. J Clin Endocrinol Metab. 2002;87(4):1762-1767.
9. Dugoff L, Hobbins JC, Malone FD, et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol. 2004;191(4):1446-1451.
10. Smith GCS, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. Early-pregnancy origins of low birth weight. Nature. 2002;417(6892):916.
11. Smith GCS, Crossley JA, Aitken DA, et al. First-trimester placentation and the risk of antepartum stillbirth. JAMA. 2004;292(18):2249-2254.
12. Smith GCS, Crossley JA, Aitken DA, et al. Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth. Obstet Gynecol. 2007;109(6):1316-1324.
13. Spencer K, Cowans NJ, Nicolaides KH. Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia. Ultrasound Obstet Gynecol. 2008;32(5):622-626.
14. Romero R, Kusanovic JP, Than NG, et al. First-trimester maternal serum PP13 in the risk assessment for preeclampsia. Am J Obstet Gynecol. 2008;199(2): 122.e1-122.e11.